News Focus
News Focus
icon url

jenna

05/30/02 12:16 PM

#6059 RE: jenna #6058

AGEN interesting play here. http://www.thestreet.com/_yahoo/tech/marketmovers/10024608.html

Antigenics, Inc. develops high efficacy, low toxicity treatments for a wide range of cancers, infectious diseases and autoimmune and degenerative disorders. The Company's cancer portfolio includes Oncophage, a personalized cancer vaccine in Phase III trials and on the FDA's Fast Track development program, and two liposomal products in Phase II development: Aroplatin, a third generation platinum chemotherapeutic, and ATRA-IV, a form of vitamin A used to treat lymphoma. Other products in development include QS-21, an antibody adjuvant being tested in several advanced clinical vaccine programs in partnership with pharmaceutical companies, and AG-702, a genital herpes therapeutic in Phase I testing.
icon url

jenna

05/31/02 7:03 PM

#6110 RE: jenna #6058

TARO finally triggered this afternoon in the 27 area and looks to move up from here. I certainly want more that the price of bus ticket from my trades and only by confidently finding those plays that have the biggest potential of upside (and downside) and staying with them, stalking them and watching them for the bigger PROFIT WILL TRADING BE WORTH WHILE.

This is why traders are waiting for a recovery and are trying to go long on down days waiting for the brass chain on the Merry Go Round. They are not confident to short, and are hoping against hope every rising wedge, bear flag, or reversal candlestick is THE ONE for the bottom and breakout.